Clopidogrel and Personalized Medicine for Cardiovascular and Cerebrovascular Disease – A Literature Review
Clopidogrel: Personalized medicine Clopidogrel is a platelet inhibitor used in patients with cardiovascular or cerebrovascular risk. It has a very narrow therapeutic index depending on the patient’s metabolism, which is influenced by CYP2C19. Based on the genotype, patients are classified